Rina Wolf

Genomind has appointed Rina Wolf to its board. She is vice president of commercialization strategies, consulting, and industry affairs at Xifin. Prior to Xifin, Wolf was an executive with commercialization and reimbursement responsibilities at several firms, including Genomic Health, RedPath Integrated Pathology, and Esoterix, now part of Laboratory Corporation of America.